نتائج البحث - Clinton F. Stewart

تنقيح النتائج
  1. 1
    Clinical Pharmacology in the Adolescent Oncology Patient

    Clinical Pharmacology in the Adolescent Oncology Patient حسب Gareth J. Veal, Christine Hartford, Clinton F. Stewart

    منشور في 2010
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Role of ATP-Binding Cassette and Solute Carrier Transporters in Erlotinib CNS Penetration and Intracellular Accumulation

    Role of ATP-Binding Cassette and Solute Carrier Transporters in Erlotinib CNS Penetration and Intracellular Accumulation حسب Mohamed Elmeliegy, Ángel M. Carcaboso, Michael Tagen, Feng Bai, Clinton F. Stewart

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Increased expression of the Abcg2 transporter during erythroid maturation plays a role in decreasing cellular protoporphyrin IX levels

    Increased expression of the Abcg2 transporter during erythroid maturation plays a role in decreasing cellular protoporphyrin IX levels حسب Sheng Zhou, Yang Zong, Paul A. Ney, Geeta Nair, Clinton F. Stewart, Brian P. Sorrentino

    منشور في 2004
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Aspirin alters methotrexate disposition in rheumatoid arthritis patients

    Aspirin alters methotrexate disposition in rheumatoid arthritis patients حسب Clinton F. Stewart, Ronald A. Fleming, Bernard F. Germain, Mitchel J. Seleznick, William E. Evans

    منشور في 1991
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature

    Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature حسب Megan O. Jacus, Vinay M. Daryani, K. Elaine Harstead, Yogesh T. Patel, Stacy L. Throm, Clinton F. Stewart

    منشور في 2015
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Topotecan Central Nervous System Penetration Is Altered by a Tyrosine Kinase Inhibitor

    Topotecan Central Nervous System Penetration Is Altered by a Tyrosine Kinase Inhibitor حسب Yanli Zhuang, Charles H. Fraga, Karen Hubbard, Nikolaus Hagedorn, John C. Panetta, Christopher M. Waters, Clinton F. Stewart

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier

    Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier حسب Vishal S. Narang, Charles H. Fraga, Narendra Kumar, Jun Shen, Stacy L. Throm, Clinton F. Stewart, Christopher M. Waters

    منشور في 2008
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children

    Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children حسب Alberto Broniscer, Lisa Iacono, Murali Chintagumpala, Maryam Fouladi, Dana Wallace, Daniel C. Bowers, Clinton F. Stewart, Matthew J. Krasin, Amar Gajjar

    منشور في 2004
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Improved Response in High-Risk Neuroblastoma With Protracted Topotecan Administration Using a Pharmacokinetically Guided Dosing Approach

    Improved Response in High-Risk Neuroblastoma With Protracted Topotecan Administration Using a Pharmacokinetically Guided Dosing Approach حسب Victor M. Santana, Wayne L. Furman, Catherine A. Billups, Fredric A. Hoffer, Andrew M. Davidoff, Peter J. Houghton, Clinton F. Stewart

    منشور في 2005
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Plasma and Cerebrospinal Fluid Pharmacokinetics of Erlotinib and Its Active Metabolite OSI-420

    Plasma and Cerebrospinal Fluid Pharmacokinetics of Erlotinib and Its Active Metabolite OSI-420 حسب Alberto Broniscer, John C. Panetta, Melinda A. O'Shaughnessy, Charles H. Fraga, Feng Bai, Matthew J. Krasin, Amar Gajjar, Clinton F. Stewart

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Phase II Study of Irinotecan and Temozolomide in Children With Relapsed or Refractory Neuroblastoma: A Children's Oncology Group Study

    Phase II Study of Irinotecan and Temozolomide in Children With Relapsed or Refractory Neuroblastoma: A Children's Oncology Group Study حسب Rochelle Bagatell, Wendy B. London, Lars M. Wagner, Stephan D. Voss, Clinton F. Stewart, John M. Maris, Cynthia S. Kretschmar, Susan L. Cohn

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Tyrosine Kinase Inhibitor Gefitinib Enhances Topotecan Penetration of Gliomas

    Tyrosine Kinase Inhibitor Gefitinib Enhances Topotecan Penetration of Gliomas حسب Ángel M. Carcaboso, Mohamed Elmeliegy, Jun Shen, Stephen J. Juel, Ziwei M. Zhang, Christopher Calabrese, Lorraine Tracey, Christopher M. Waters, Clinton F. Stewart

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Ocular Salvage and Vision Preservation Using a Topotecan-Based Regimen for Advanced Intraocular Retinoblastoma

    Ocular Salvage and Vision Preservation Using a Topotecan-Based Regimen for Advanced Intraocular Retinoblastoma حسب Rachel C. Brennan, Ibrahim Qaddoumi, Shenghua Mao, Jianrong Wu, Catherine A. Billups, Clinton F. Stewart, Mary Ellen Hoehn, Carlos Rodríguez‐Galindo, Matthew W. Wilson

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high‐grade and diffuse intrinsic pontine glioma

    Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high‐grade and diffuse intrinsic pontine gliom... حسب Alberto Broniscer, Sujuan Jia, Belinda N. Mandrell, Dima Hamideh, Jie Huang, Arzu Onar‐Thomas, Amar Gajjar, Susana C. Raimondi, Ruth Tatevossian, Clinton F. Stewart

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1+/−p53−/− mice

    Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1+/−p53−/− mice حسب Justyna T. Romer, Hiromichi Kimura, Susan Magdaleno, Ken Sasai, Christine Fuller, Helen Baines, Michele Connelly, Clinton F. Stewart, Stephen E. Gould, Lee L. Rubin, Tom Curran

    منشور في 2004
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Pharmacokinetic Modeling of an Induction Regimen for In Vivo Combined Testing of Novel Drugs against Pediatric Acute Lymphoblastic Leukemia Xenografts

    Pharmacokinetic Modeling of an Induction Regimen for In Vivo Combined Testing of Novel Drugs against Pediatric Acute Lymphoblastic Leukemia Xenografts حسب Barbara Szymanska, Urszula Wilczynska-Kalak, Min H. Kang, Natalia Liem, Hernán Carol, Ingrid Boehm, Daniel Groepper, C. Patrick Reynolds, Clinton F. Stewart, Richard B. Lock

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Targeting the p53 Pathway in Retinoblastoma with Subconjunctival Nutlin-3a

    Targeting the p53 Pathway in Retinoblastoma with Subconjunctival Nutlin-3a حسب Rachel C. Brennan, Sara M. Federico, Cori Bradley, Jiakun Zhang, Jacqueline Flores‐Otero, Matthew W. Wilson, Clinton F. Stewart, Fangyi Zhu, Kip Guy, Michael A. Dyer

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Pilot Induction Regimen Incorporating Pharmacokinetically Guided Topotecan for Treatment of Newly Diagnosed High-Risk Neuroblastoma: A Children's Oncology Group Study

    Pilot Induction Regimen Incorporating Pharmacokinetically Guided Topotecan for Treatment of Newly Diagnosed High-Risk Neuroblastoma: A Children's Oncology Group Study حسب Julie R. Park, Jeffrey R. Scott, Clinton F. Stewart, Wendy B. London, Arlene Naranjo, Victor M. Santana, Peter J. Shaw, Susan L. Cohn, Katherine K. Matthay

    منشور في 2011
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: A report from the Pediatric Brain Tumor Consortium

    A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: A report from the Pediatric Brain Tumor Consortium حسب Ian F. Pollack, Clinton F. Stewart, Mehmet Koçak, Tina Young Poussaint, Alberto Broniscer, Anuradha Banerjee, James G. Douglas, L. Kun, James M. Boyett, J. Russell Geyer

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Phase II evaluation of sunitinib in the treatment of recurrent or refractory high‐grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021

    Phase II evaluation of sunitinib in the treatment of recurrent or refractory high‐grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021 حسب Cynthia Wetmore, Vinay M. Daryani, Catherine A. Billups, James M. Boyett, Sarah Leary, Rachel Tanos, Kelly C. Goldsmith, Clinton F. Stewart, Susan M. Blaney, Amar Gajjar

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: